Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 5:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 153 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Social Status Condition Clear all

Conditions: Chronic Heart Failure, Chronic Obstructive Pulmonary Disorder
Interventions: BOOST High Protein; Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 20 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Concussion, Brain
Interventions: Education; Other
Lead sponsor: Stanford University; Other
Eligibility: 14 Years to 19 Years · Male only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostatic Neoplasms
Interventions: Radiotherapy, LHRHa, Apalutamide; Radiation · Drug
Lead sponsor: Janssen Pharmaceutica N.V., Belgium; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 691 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 13
States / cities: Tucson, Arizona • Little Rock, Arkansas • Lakewood, Colorado + 10 more

Conditions: Cardiovascular Diseases
Interventions: Nutrition, Exercise, Stress Management Counseling, usual care; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Vitamin D Deficiency, Cystic Fibrosis
Interventions: High-Dose Vitamin D3, Stool Sample, Sputum Sample, Sham Comparator, Blood draw; Dietary Supplement · Other · Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Tobacco-Related Carcinoma
Interventions: Discrete Choice Study, Survey Administration; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 15 Years and older
Enrollment: 3,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthy Aging
Interventions: There is no intervention; Other
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 35 Years to 70 Years
Enrollment: 32 participants
Timeline: 2022
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: COPD, Chronic Bronchitis
Interventions: N-Acetylcysteine, Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 40 Years to 85 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Type 1 Diabetes
Interventions: Social Determinants of Health (SDOH) Screening and Referral; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 21 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Consumer Behavior, Consumer Preference
Interventions: front-of-package modification; Behavioral
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: 18 Years and older
Enrollment: 5,028 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Human Papillomavirus Infection
Interventions: APTIMA HPV Assay, FDA-Approved HPV DNA Test; Device
Lead sponsor: Gen-Probe, Incorporated; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 12,896 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 17
States / cities: Jonesboro, Arkansas • Canoga Park, California • Los Angeles, California + 13 more

Conditions: Melanoma
Interventions: Pembrolizumab, Interleukin-2; Drug
Lead sponsor: Ralph Hauke; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diabetes Mellitus
Interventions: HBOT intervention, Sham intervention; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: New York, New York • Madison, Wisconsin

Conditions: Central Auditory Processing Disorder, Traumatic Brain Injury, Hearing Loss
Interventions: Audiological testing; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Anorexia Nervosa/Bulimia, Anorexia Nervosa Restricting Type, Eating Disorders in Adolescence
Interventions: Family Based Treatment, Enhanced Cognitive Behavioral Therapy; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Alcohol Use Disorder
Interventions: Beer, Videotaped drinking session; Drug · Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 55 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Acute Lymphocytic Leukemia, Lymphoma
Interventions: Biological/Genetically Modified T cells, Cyclophosphamide-based chemotherapy; Biological · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Myelodysplastic Syndrome
Interventions: Entinostat, Pembrolizumab; Drug · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 19
States / cities: New Haven, Connecticut • Washington D.C., District of Columbia • Chicago, Illinois + 13 more

Conditions: Hyperlipidemia, Elevated Lp(a)
Interventions: 2-HOBA (Hobamine); Dietary Supplement
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 69 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Treatment Resistant Depression
Interventions: Genotyping assays; Genetic
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rheumatoid Arthritis, Interstitial Lung Disease
Interventions: Research Testing Performed (Laboratory), Information Collected as Standard of Care, Research Testing Performed; Genetic · Diagnostic Test · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 90 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2034
U.S. locations: 4
States / cities: San Francisco, California • Aurora, Colorado • Kansas City, Kansas + 1 more

Conditions: Osteoid Osteoma
Interventions: MR-HIFU treatment; Device
Lead sponsor: Children's National Research Institute; Other
Eligibility: 0 Years to 30 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: High-risk Diffuse Large B-cell Lymphoma
Interventions: Blinatumomab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Atlanta, Georgia • Maywood, Illinois • Cleveland, Ohio + 1 more

Conditions: Essential Tremor
Interventions: MRI and fMRI scans, MEG, Sensor-based motor assessments, Clinical evaluations, Questionnaires and rating scales that; Diagnostic Test · Other
Lead sponsor: University of Florida; Other
Eligibility: 50 Years to 84 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Nutritional and Functional Changes in Heart Failure and COPD

Comparison of Concussion Education Programs

A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

Novel Strategies for Reducing Heart Disease Risk Disparities

Vitamin D and Microbiota in Cystic Fibrosis

Studying the Impacts of Higher Taxes and Bans on Electronic Cigarettes to Improve Public Health

Race and Socioeconomic Position: Examining Common Social Pathways to Disease Risk

N-Acetylcysteine for Patients With COPD and Chronic Bronchitis

Screening For Social Determinants Of Health In Routine Diabetes Care

Front-of-package Marketing on Fruit Drinks: Online RCT

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma

Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk

Central Auditory Processing Disorders Associated With Blast Exposure

Project CORE: Disseminating Eating Disorders Treatment

Alcohol Use and Mental Health - Pilot Test of Video-assisted Drinking Topography

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents

2-HOBA Supplementation in People With Elevated Lipoprotein(a)

Pharmacogenomics for Antidepressant Guidance and Education

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

MR-HIFU Treatment of Painful Osteoid Osteoma

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

Magnetoencephalography (MEG) Pilot Study